Navigation Links
How and why did 2011 Nobel winner Dan Shechtman persist despite rejection?
Date:10/14/2011

On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.

On October 5, 2011, Shechtman received the Nobel Prize in Chemistry.

What compelled Shechtman to stand by his research? What drove the men and women behind the most paradigm-shifting findings of the twentieth century? What motivates those few scientists who rise above their peers to achieve breakthrough discoveries?

In order to answer such questions, physical chemist and author Istvan Hargittai examines the careers of fifteen eminent scientists who achieved some of the most notable discoveries of the past century, assessing their motivation. In Drive and Curiosity, Dr. Hargittai provides an insider's perspective on the history of twentieth-century science. The author, who was personally acquainted with all but two of the scientists he profiles, includes:

  • Dan Shechtman, the aforementioned 2011 Nobel laureate and discoverer of quasicrystals
  • James D. Watson, the Nobel laureate and codiscoverer of the double helix structure of DNA
  • Linus Pauling, the Nobel laureate remembered most for his work on the structure of proteins
  • Edward Teller, a giant of the twentieth century who accomplished breakthroughs in our understanding of nuclear fusion
  • George Gamow, a pioneering scientist who devised the initially ridiculed and now accepted Big Bang

"Is there a recipe for research successes reaching the highest pinnacles? What are the common characteristics of discoveries that profoundly alter the world we live in?" asks Richard N. Zare, Stanford University, Wolf Prize laureate. "This fascinating book presents fifteen case studies that explore these questions in a manner both inviting and at once accessible."

In each case, Hargittai has uncovered a singular personality characteristic, motivational factor, or circumstance that, in addition to their extraordinary drive and curiosity, led these scientists to make outstanding contributions. For example, Gertrude B. Elion, who discovered drugs that saved millions of lives, was motivated to find new medications after the deaths of her grandfather and later her fianc. F. Sherwood Rowland, who stumbled upon the environmental harm caused by chlorofluorocarbons, eventually felt a moral imperative to become an environmental activist. Rosalyn Yalow, the codiscoverer of the radioimmunoassay, always felt she had to prove herself in the face of prejudice against her as a woman.

When it comes to "science, discovery and scientists," adds Nobel laureate Jean-Marie Lehn, it matters to be "the right person, at the right time, in the right place. This book provides a thoughtful and vivid analysis of how scientific progress happens through some selected case studies. It should be of value to [anyone] who wishes to get insight into the various processes underlying the quest for knowledge."


'/>"/>
Contact: Meghan Quinn
mquinn@prometheusbooks.com
800-853-7545
Prometheus Books
Source:Eurekalert  

Related medicine news :

1. Nobel Prize in Physiology or Medicine 2011: Jules Hoffmann
2. UT Southwestern scientist shares 2011 Nobel Prize in Physiology or Medicine
3. Lifespan researcher wins Ig Nobel Prize
4. Nobel laureates Brown, Goldstein to give inaugural Stadtman award lecture
5. 2010 Chemistry Nobel laureate Ei-ichi Negishi leads C&EN webinar
6. NIDA Avant-Garde-Medications Development Award winners announced
7. HJF names 2011-12 fellowship award winners
8. Joint winners announced in Research4life global case study competition
9. BUS Jeffrey H. Samet, M.D., selected as a 2011 NIDA International Program Awards of Excellence winner
10. Reed Elsevier Environmental Challenge winners announced
11. Cephalalgia Award Lecture winner announced
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
How and why did 2011 Nobel winner Dan Shechtman persist despite rejection?
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... For Coast ... hygienist Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. to ... dozens of dental professionals, donating their time and skills to help hundreds of uninsured ...
(Date:2/12/2016)... DC (PRWEB) , ... February 12, 2016 , ... ... “Managing High-Cost Drug Categories: Strategies for Health Plans and PBMs,” an upcoming Feb. ... to maintain affordability and access in big-dollar therapeutic categories, such as the $1,000-per-pill ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Healthcare careers in ... five most searched jobs via the website of healthcare staffing leader Aureus Medical Group ... travel nurse jobs , travel therapy positions and in travel and direct ...
(Date:2/12/2016)... ... ... Basketball is a game for everyone, not just those who can hear! ... translation is featured in the top right of the screen. Every technique that is ... sign language translator to teach kids the game and how to be as active ...
(Date:2/11/2016)... ... February 12, 2016 , ... Fitbody Personal Training offers ... fun and exciting way to get fit and healthy. Located in Phoenixville, PA, the ... for a class designed for horseback riders who want to lose weight and tone ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
(Date:2/11/2016)... 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ), ... lives of pets, today announced the submission to FDA ... Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive ... Zimeta for the control of pyrexia (fever) in horses ... --> --> The Chemistry, Manufacturing, and ...
Breaking Medicine Technology: